Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 392

1.

Kidney-Detrimental Factors and Estimated Glomerular Filtration Rate in Preterm Newborns: The Role of Nutrition.

Monzani A, Crespi I, Genoni G, Edefonti A, Montini G, Bellomo G, Ferrero F, Bellone S, Prodam F.

Nutrients. 2020 Feb 28;12(3). pii: E651. doi: 10.3390/nu12030651.

2.

Multivariate Curve Resolution for 2D Solid-State NMR spectra.

Bruno F, Francischello R, Bellomo G, Gigli L, Flori A, Menichetti L, Tenori L, Luchinat C, Ravera E.

Anal Chem. 2020 Mar 17;92(6):4451-4458. doi: 10.1021/acs.analchem.9b05420. Epub 2020 Mar 3.

PMID:
32069028
3.

Integrated care pathways on dementia in Italy: a survey testing the compliance with a national guidance.

Gervasi G, Bellomo G, Mayer F, Zaccaria V, Bacigalupo I, Lacorte E, Canevelli M, Corbo M, Di Fiandra T, Vanacore N.

Neurol Sci. 2019 Dec 13. doi: 10.1007/s10072-019-04184-9. [Epub ahead of print]

PMID:
31836948
4.

The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction.

Bellomo G, Paciotti S, Gatticchi L, Parnetti L.

Mov Disord. 2020 Jan;35(1):34-44. doi: 10.1002/mds.27895. Epub 2019 Nov 15. Review.

PMID:
31729779
5.

Transient protein accumulation at the center of the T cell antigen-presenting cell interface drives efficient IL-2 secretion.

Clark DJ, McMillan LE, Tan SL, Bellomo G, Massoue C, Thompson H, Mykhaylechko L, Alibhai D, Ruan X, Singleton KL, Du M, Hedges A, Schwartzberg PL, Verkade P, Murphy RF, Wülfing C.

Elife. 2019 Oct 30;8. pii: e45789. doi: 10.7554/eLife.45789.

6.

The issue of waste disposal in Parkinson's disease pathogenesis.

Parnetti L, Bellomo G.

Mov Disord. 2019 Jul;34(7):985. doi: 10.1002/mds.27734. Epub 2019 May 30. No abstract available.

PMID:
31145819
7.

Parkinson's and Lewy body dementia CSF biomarkers.

Parnetti L, Paciotti S, Farotti L, Bellomo G, Sepe FN, Eusebi P.

Clin Chim Acta. 2019 Aug;495:318-325. doi: 10.1016/j.cca.2019.04.078. Epub 2019 Apr 30. Review.

PMID:
31051162
8.

Dissecting the Interactions between Human Serum Albumin and α-Synuclein: New Insights on the Factors Influencing α-Synuclein Aggregation in Biological Fluids.

Bellomo G, Bologna S, Cerofolini L, Paciotti S, Gatticchi L, Ravera E, Parnetti L, Fragai M, Luchinat C.

J Phys Chem B. 2019 May 23;123(20):4380-4386. doi: 10.1021/acs.jpcb.9b02381. Epub 2019 May 9.

PMID:
31034772
9.

K Index is a Reliable Marker of Intrathecal Synthesis, and an Alternative to IgG Index in Multiple Sclerosis Diagnostic Work-Up.

Crespi I, Vecchio D, Serino R, Saliva E, Virgilio E, Sulas MG, Bellomo G, Dianzani U, Cantello R, Comi C.

J Clin Med. 2019 Apr 2;8(4). pii: E446. doi: 10.3390/jcm8040446.

10.

Kappa free light chains could predict early disease course in multiple sclerosis.

Vecchio D, Crespi I, Virgilio E, Naldi P, Campisi MP, Serino R, Dianzani U, Bellomo G, Cantello R, Comi C.

Mult Scler Relat Disord. 2019 May;30:81-84. doi: 10.1016/j.msard.2019.02.001. Epub 2019 Feb 5.

PMID:
30738877
11.

Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents.

Gualerzi A, Bellan M, Smirne C, Tran Minh M, Rigamonti C, Burlone ME, Bonometti R, Bianco S, Re A, Favretto S, Bellomo G, Minisini R, Carnevale Schianca GP, Pirisi M.

PLoS One. 2018 Dec 20;13(12):e0209216. doi: 10.1371/journal.pone.0209216. eCollection 2018.

12.

Lipoprotein-associated phospholipase A2 predicts cardiovascular events in dialyzed patients.

De Mauri A, Vidali M, Chiarinotti D, Bellomo G, Rolla R.

J Nephrol. 2019 Apr;32(2):283-288. doi: 10.1007/s40620-018-0521-3. Epub 2018 Aug 27.

PMID:
30168082
13.

Are We Ready for Detecting α-Synuclein Prone to Aggregation in Patients? The Case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as Diagnostic Tools.

Paciotti S, Bellomo G, Gatticchi L, Parnetti L.

Front Neurol. 2018 Jun 6;9:415. doi: 10.3389/fneur.2018.00415. eCollection 2018. Review.

14.

Aggregation kinetics of the Aβ1-40 peptide monitored by NMR.

Bellomo G, Bologna S, Gonnelli L, Ravera E, Fragai M, Lelli M, Luchinat C.

Chem Commun (Camb). 2018 Jul 14;54(55):7601-7604. doi: 10.1039/c8cc01710g. Epub 2018 May 16.

PMID:
29767190
15.

Resource-theoretic approach to vectorial coherence.

Bosyk GM, Bellomo G, Luis A.

Opt Lett. 2018 Apr 1;43(7):1463-1466. doi: 10.1364/OL.43.001463.

PMID:
29601005
16.

High-normal estimated glomerular filtration rate and hyperuricemia positively correlate with metabolic impairment in pediatric obese patients.

Ricotti R, Genoni G, Giglione E, Monzani A, Nugnes M, Zanetta S, Castagno M, Marolda A, Bellomo G, Bona G, Bellone S, Prodam F.

PLoS One. 2018 Mar 5;13(3):e0193755. doi: 10.1371/journal.pone.0193755. eCollection 2018.

17.

The lattice of trumping majorization for 4D probability vectors and 2D catalysts.

Bosyk GM, Freytes H, Bellomo G, Sergioli G.

Sci Rep. 2018 Feb 27;8(1):3671. doi: 10.1038/s41598-018-21947-0.

18.

Uric Acid: The Lower the Better?

Bellomo G, Selvi A.

Contrib Nephrol. 2018;192:69-76. doi: 10.1159/000484280. Epub 2018 Jan 23.

PMID:
29393097
19.

Impact of adenosine A2a receptor polymorphism rs5751876 on platelet reactivity in ticagrelor treated patients.

Nardin M, Verdoia M, Pergolini P, Rolla R, Barbieri L, Marino P, Bellomo G, Kedhi E, Suryapranata H, Carriero A, De Luca G; Novara Atherosclerosis Study Group (NAS).

Pharmacol Res. 2018 Mar;129:27-33. doi: 10.1016/j.phrs.2017.12.035. Epub 2018 Jan 31.

PMID:
29355684
20.

Lossless quantum data compression with exponential penalization: an operational interpretation of the quantum Rényi entropy.

Bellomo G, Bosyk GM, Holik F, Zozor S.

Sci Rep. 2017 Nov 7;7(1):14765. doi: 10.1038/s41598-017-13350-y.

21.

Impact of Long-Term Dual Antiplatelet Therapy on Immature Platelet Count and Platelet Reactivity.

Verdoia M, Pergolini P, Rolla R, Barbieri L, Schaffer A, Marino P, Bellomo G, Suryapranata H, De Luca G; Novara Atherosclerosis Study Group (NAS).

Angiology. 2018 Jul;69(6):490-496. doi: 10.1177/0003319717736407. Epub 2017 Oct 29.

PMID:
29082748
22.

Impact of polymorphism rs7041 and rs4588 of Vitamin D Binding Protein on the extent of coronary artery disease.

Daffara V, Verdoia M, Rolla R, Nardin M, Marino P, Bellomo G, Carriero A, De Luca G; Novara Atherosclerosis Study Group (NAS).

Nutr Metab Cardiovasc Dis. 2017 Sep;27(9):775-783. doi: 10.1016/j.numecd.2017.06.002. Epub 2017 Jun 24.

PMID:
28779988
23.

Vitamin B12, folate and homocysteine status in obese and atopic children: a preliminary study.

Savastio S, Donis M, Grasso N, Bellomo G, Bona G.

Minerva Pediatr. 2018 Apr;70(2):201-202. doi: 10.23736/S0026-4946.17.04955-6. Epub 2017 May 31. No abstract available.

PMID:
28565898
24.

A case of false positive Troponin I in a patient affected by cryoglobulinemic vasculitis.

Bellan M, Pirisi M, Bellomo G, Sainaghi PP.

Reumatismo. 2017 May 22;69(1):40-42. doi: 10.4081/reumatismo.2017.941.

25.

Vitamin D Binding Protein rs7041 polymorphism and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.

Verdoia M, Daffara V, Pergolini P, Rolla R, Marino P, Bellomo G, Carriero A, De Luca G; Novara Atherosclerosis Study Group (NAS).

Vascul Pharmacol. 2017 Aug;93-95:42-47. doi: 10.1016/j.vph.2017.04.001. Epub 2017 Apr 19.

PMID:
28433569
26.

Immature platelet fraction and the extent of coronary artery disease: A single centre study.

Verdoia M, Nardin M, Rolla R, Marino P, Bellomo G, Suryapranata H, De Luca G; Novara Atherosclerosis Study Group (NAS).

Atherosclerosis. 2017 May;260:110-115. doi: 10.1016/j.atherosclerosis.2017.03.044. Epub 2017 Mar 31.

PMID:
28388444
27.

Combined use of Kappa Free Light Chain Index and Isoelectrofocusing of Cerebro-Spinal Fluid in Diagnosing Multiple Sclerosis: Performances and Costs.

Crespi I, Sulas MG, Mora R, Naldi P, Vecchio D, Comi C, Cantello R, Bellomo G.

Clin Lab. 2017 Mar 1;63(3):551-559. doi: 10.7754/Clin.Lab.2016.160930.

PMID:
28271695
28.

Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease.

Verdoia M, Pergolini P, Rolla R, Nardin M, Schaffer A, Barbieri L, Daffara V, Marino P, Bellomo G, Suryapranata H, De Luca G; Novara Atherosclerosis Study Group (NAS).

Thromb Res. 2017 Feb;150:90-95. doi: 10.1016/j.thromres.2016.12.019. Epub 2016 Dec 28.

PMID:
28068529
29.

MR Spectroscopy in Prostate Cancer: New Algorithms to Optimize Metabolite Quantification.

Bellomo G, Marcocci F, Bianchini D, Mezzenga E, D'Errico V, Menghi E, Zannoli R, Sarnelli A.

PLoS One. 2016 Nov 10;11(11):e0165730. doi: 10.1371/journal.pone.0165730. eCollection 2016.

30.

Vitamin D Deficiency and Glycemic Status in Children and Adolescents with Type 1 Diabetes Mellitus.

Savastio S, Cadario F, Genoni G, Bellomo G, Bagnati M, Secco G, Picchi R, Giglione E, Bona G.

PLoS One. 2016 Sep 8;11(9):e0162554. doi: 10.1371/journal.pone.0162554. eCollection 2016.

31.

Vitamin D levels and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.

Verdoia M, Pergolini P, Rolla R, Sartori C, Nardin M, Schaffer A, Barbieri L, Daffara V, Marino P, Bellomo G, Suryapranata H, De Luca G; Novara Atherosclerosis Study Group (NAS).

Platelets. 2016 Sep;27(6):576-82. doi: 10.3109/09537104.2016.1149159. Epub 2016 Apr 11.

PMID:
27540959
32.

Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation.

Verdoia M, Schaffer A, Barbieri L, Di Giovine G, Bellomo G, Marino P, Suryapranata H, De Luca G.

Neth Heart J. 2016 Jul;24(7-8):462-74. doi: 10.1007/s12471-016-0850-6.

33.

Polymorphisms Associated with Increased Cardiovascular Risk in the General Population do not Predict Acute Events in Hemodialysis Patients.

Rolla R, De Mauri A, Vidali M, Valsesia A, Chiarinotti D, Bellomo G.

Clin Lab. 2016;62(4):639-44.

PMID:
27215083
34.

Diabetes mellitus, glucose control parameters and platelet reactivity in ticagrelor treated patients.

Nardin M, Verdoia M, Sartori C, Pergolini P, Rolla R, Barbieri L, Schaffer A, Bellomo G, Suryapranata H, De Luca G; Novara Atherosclerosis Study Group (NAS).

Thromb Res. 2016 Jul;143:45-9. doi: 10.1016/j.thromres.2016.04.021. Epub 2016 Apr 27. No abstract available.

PMID:
27179132
35.

Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study.

Nardin M, Verdoia M, Pergolini P, Rolla R, Barbieri L, Schaffer A, Marino P, Bellomo G, Suryapranata H, De Luca G; Novara Atherosclerosis Study Group (NAS).

Nutr Metab Cardiovasc Dis. 2016 Jul;26(7):567-574. doi: 10.1016/j.numecd.2016.03.001. Epub 2016 Mar 15.

PMID:
27134063
36.

Parathyroid Hormone Levels and High-Residual Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy With Acetylsalicylic Acid and Clopidogrel or Ticagrelor.

Verdoia M, Pergolini P, Rolla R, Nardin M, Barbieri L, Schaffer A, Bellomo G, Marino P, Suryapranata H, De Luca G; Novara Atherosclerosis Study Group (NAS).

Cardiovasc Ther. 2016 Aug;34(4):209-15. doi: 10.1111/1755-5922.12188.

37.

Impact of renal function on mean platelet volume and its relationship with coronary artery disease: A single-centre cohort study.

Verdoia M, Barbieri L, Schaffer A, Bellomo G, Marino P, De Luca G; Novara Atherosclerosis Study (NAS) group.

Thromb Res. 2016 May;141:139-44. doi: 10.1016/j.thromres.2016.03.018. Epub 2016 Mar 19.

PMID:
27039166
38.

Impact of diabetes on immature platelets fraction and its relationship with platelet reactivity in patients receiving dual antiplatelet therapy.

Verdoia M, Pergolini P, Nardin M, Rolla R, Barbieri L, Schaffer A, Marino P, Bellomo G, Suryapranata H, De Luca G.

J Thromb Thrombolysis. 2016 Aug;42(2):245-53. doi: 10.1007/s11239-016-1348-1.

PMID:
26951167
39.

Gender Differences in Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy.

Verdoia M, Pergolini P, Rolla R, Nardin M, Barbieri L, Daffara V, Marino P, Bellomo G, Suryapranata H, Luca GD; Novara Atherosclerosis Study Group (NAS).

Cardiovasc Drugs Ther. 2016 Apr;30(2):143-50. doi: 10.1007/s10557-016-6646-5.

PMID:
26868495
40.

Uric acid and high-residual platelet reactivity in patients treated with clopidogrel or ticagrelor.

Barbieri L, Verdoia M, Pergolini P, Nardin M, Rolla R, Marino P, Bellomo G, Suryapranata H, De Luca G; Novara Atherosclerosis Study Group (NAS).

Nutr Metab Cardiovasc Dis. 2016 Apr;26(4):352-8. doi: 10.1016/j.numecd.2015.12.015. Epub 2016 Jan 6.

PMID:
26857781
41.

Increased Urinary Cystatin-C Levels Correlate with Reduced Renal Volumes in Neonates with Intrauterine Growth Restriction.

Barbati A, Cappuccini B, Aisa MC, Grasselli C, Zamarra M, Bini V, Bellomo G, Orlacchio A, Di Renzo GC.

Neonatology. 2016;109(2):154-60. doi: 10.1159/000441273. Epub 2016 Jan 13.

PMID:
26756983
42.

"Real life use" of troponin in the emergency department: a survey of over 3000 cases.

Vidali M, Verzotti E, Cabraz N, Santi F, Puma A, Bellomo G, Lupi A, Lippi G, Avanzi GC.

Biochem Med (Zagreb). 2015 Oct 15;25(3):421-9. doi: 10.11613/BM.2015.043. eCollection 2015.

43.

Impact of atorvastatin or rosuvastatin co-administration on platelet reactivity in patients treated with dual antiplatelet therapy.

Verdoia M, Nardin M, Sartori C, Pergolini P, Rolla R, Barbieri L, Marino P, Bellomo G, Suryapranata H, De Luca G; Novara Atherosclerosis Study Group (NAS).

Atherosclerosis. 2015 Dec;243(2):389-94. doi: 10.1016/j.atherosclerosis.2015.10.005. Epub 2015 Oct 9.

PMID:
26520891
44.

Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor.

Barbieri L, Pergolini P, Verdoia M, Rolla R, Nardin M, Marino P, Bellomo G, Suryapranata H, De Luca G; Novara Atherosclerosis Study Group (NAS).

Vascul Pharmacol. 2016 Apr;79:11-15. doi: 10.1016/j.vph.2015.10.006. Epub 2015 Oct 28.

PMID:
26518440
45.

Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.

Verdoia M, Pergolini P, Rolla R, Nardin M, Schaffer A, Barbieri L, Marino P, Bellomo G, Suryapranata H, De Luca G.

J Thromb Haemost. 2016 Jan;14(1):57-64. doi: 10.1111/jth.13177. Epub 2015 Dec 29.

46.

Platelet Larger Cell Ratio and High-on Treatment Platelet Reactivity During Dual Antiplatelet Therapy.

Verdoia M, Pergolini P, Rolla R, Nardin M, Barbieri L, Schaffer A, Bellomo G, Marino P, Suryapranata H, De Luca G; Novara Atherosclerosis Study Group (NAS).

Cardiovasc Drugs Ther. 2015;29(5):443-50. doi: 10.1007/s10557-015-6616-3.

PMID:
26428927
47.

Immature platelet fraction and high-on treatment platelet reactivity with ticagrelor in patients with acute coronary syndromes.

Verdoia M, Sartori C, Pergolini P, Nardin M, Rolla R, Barbieri L, Schaffer A, Marino P, Bellomo G, Suryapranata H, De Luca G.

J Thromb Thrombolysis. 2016 May;41(4):663-70. doi: 10.1007/s11239-015-1279-2.

PMID:
26370198
48.

Asymptomatic hyperuricemia following renal transplantation.

Bellomo G.

World J Nephrol. 2015 Jul 6;4(3):324-9. doi: 10.5527/wjn.v4.i3.324.

49.

Impact of diabetes on fibrinogen levels and its relationship with platelet reactivity and coronary artery disease: A single-centre study.

Di Giovine G, Verdoia M, Barbieri L, Schaffer A, Aimaretti G, Bellomo G, Marino P, Suryapranata H, Sinigaglia F, De Luca G; Novara Atherosclerosis Study (NAS) group.

Diabetes Res Clin Pract. 2015 Sep;109(3):541-50. doi: 10.1016/j.diabres.2015.05.038. Epub 2015 May 18.

PMID:
26163440
50.

High Prevalence of Vitamin D Deficiency in Native versus Migrant Mothers and Newborns in the North of Italy: A Call to Act with a Stronger Prevention Program.

Cadario F, Savastio S, Magnani C, Cena T, Pagliardini V, Bellomo G, Bagnati M, Vidali M, Pozzi E, Pamparana S, Zaffaroni M, Genoni G, Bona G.

PLoS One. 2015 Jun 11;10(6):e0129586. doi: 10.1371/journal.pone.0129586. eCollection 2015.

Supplemental Content

Loading ...
Support Center